For instance, TP53 alterations were more prevalent in the GBC; SMAD4 alterations were more prevalent in the ECC, but APC alterations were mainly enriched in the ICC instead. The gene discussed is SMAD4; the disease is intrahepatic cholangiocarcinoma.